No photo of Krister Wennerberg

Krister Wennerberg

  • PL 20 (Tukholmankatu 8)

    00014

    Finland

  • Viikinkaari 5, Biocenter 2

    00790 Helsinki

    Finland

19962020

Research output per year

If you made any changes in Pure these will be visible here soon.

Personal profile

Fields of Science

  • 3111 Biomedicine
  • 3122 Cancers
  • 318 Medical biotechnology

International and National Collaboration Publications and projects within past five years.

Publications

ALDH1A1-related stemness in high-grade serous ovarian cancer is a negative prognostic indicator but potentially targetable by EGFR/mTOR-PI3K/aurora kinase inhibitors

Kaipio, K., Chen, P., Roering, P., Huhtinen, K., Mikkonen, P., Östling, P., Lehtinen, L., Mansuri, N., Korpela, T., Potdar, S., Hynninen, J., Auranen, A., Grénman, S., Wennerberg, K., Hautaniemi, S. & Carpén, O., Feb 2020, In : Journal of Pathology. 250, 2, p. 159-169 11 p.

Research output: Contribution to journalArticleScientificpeer-review

A normalized drug response metric improves accuracy and consistency of anticancer drug sensitivity quantification in cell-based screening

Gupta, A., Gautam, P., Wennerberg, K. & Aittokallio, T., 23 Jan 2020, In : Communications Biology. 3, 1, 12 p., 42.

Research output: Contribution to journalArticleScientificpeer-review

Open Access
File

Atypical KRAS(G12R) Mutant Is Impaired in PI3K Signaling and Macropinocytosis in Pancreatic Cancer

Hobbs, G. A., Baker, N. M., Miermont, A. M., Thurman, R. D., Pierobon, M., Tran, T. H., Anderson, A. O., Waters, A. M., Diehl, J. N., Papke, B., Hodge, R. G., Klomp, J. E., Goodwin, C. M., DeLiberty, J. M., Wang, J., Ng, R. W. S., Gautam, P., Bryant, K. L., Esposito, D., Campbell, S. L. & 8 others, Petricoin, E. F., Simanshu, D. K., Aguirre, A. J., Wolpin, B. M., Wennerberg, K., Rudloff, U., Cox, A. D. & Der, C. J., Jan 2020, In : Cancer Discovery. 10, 1, p. 104-123 20 p.

Research output: Contribution to journalArticleScientificpeer-review

Open Access
File

Human Tumor-Derived Matrix Improves the Predictability of Head and Neck Cancer Drug Testing

Tuomainen, K., Al-Samadi, A., Potdar, S., Turunen, L., Turunen, M., Karhemo, P-R., Bergman, P., Risteli, M., Åström, P., Tiikkaja, R., Grenman, R., Wennerberg, K., Monni, O. & Salo, T., Jan 2020, In : Cancers. 12, 1, 15 p., 92.

Research output: Contribution to journalArticleScientificpeer-review

Open Access
File

Projects

Prizes

The 2017 SLAS Technology Ten

Evgeny Kulesskiy (Recipient), Jani Sakari Saarela (Recipient), Laura Leena Turunen (Recipient) & Johan Krister Wennerberg (Recipient), 1 Feb 2017

Prize: Prizes and awards

Activities

Phenotypic based drug discovery: industry savior or wasteful distraction?

Krister Wennerberg (Speaker: Presenter)
29 Apr 2014

Activity: Participating in or organising an event typesOrganisation and participation in conferences, workshops, courses, seminars

AACR annual meeting 2014

Krister Wennerberg (Attendee)
5 Apr 20149 Apr 2014

Activity: Participating in or organising an event typesOrganisation and participation in conferences, workshops, courses, seminars

FPDP-D annual meeting

Krister Wennerberg (Attendee)
26 Mar 201427 Mar 2014

Activity: Participating in or organising an event typesOrganisation and participation in conferences, workshops, courses, seminars

The 5th Meeting of The Nordic EMBL Partnership for Molecular Medicine

Krister Wennerberg (Attendee)
26 Aug 201428 Aug 2014

Activity: Participating in or organising an event typesOrganisation and participation in conferences, workshops, courses, seminars

Nordic Chemical Biology Consortium meeting

Krister Wennerberg (Speaker: Presenter)
8 May 2014

Activity: Participating in or organising an event typesOrganisation and participation in conferences, workshops, courses, seminars